Black Diamond Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Black Diamond Therapeutics's estimated annual revenue is currently $14.4M per year.
- Black Diamond Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Black Diamond Therapeutics has 93 Employees.
- Black Diamond Therapeutics grew their employee count by -23% last year.
Black Diamond Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $4.2M | 27 | 35% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $1.4M | 9 | 29% | N/A | N/A |
#6 | $235M | 255 | -31% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.3M | 34 | 0% | N/A | N/A |
#10 | $1.9M | 12 | -8% | N/A | N/A |
What Is Black Diamond Therapeutics?
Black Diamond Therapeutics Inc. is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.
keywords:N/AN/A
Total Funding
93
Number of Employees
$14.4M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Black Diamond Therapeutics News
Black Diamond Therapeutics, Inc., a Cambridge, Mass.-based precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, completed a Series C financing of $85m. The round was led by Boxer Capital of the Tavistock Group, with participat ...
Black Diamond Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company developing next-generation precision medicines for cancer, completed an $85m Series B financing. The round was co-led by New Enterprise Associates and RA Capital Management, with participation from new investors Ne ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.2M | 93 | -4% | N/A |
#2 | $23.3M | 93 | 27% | N/A |
#3 | $14.4M | 93 | 52% | N/A |
#4 | $12.1M | 93 | 8% | N/A |
#5 | $13M | 93 | -13% | N/A |